Investment to Advance Test for Diagnosing Early Alzheimer’s Disease
ROCKVILLE, MD — The announcement of a recent investment from Semler Scientific (SMLR) in SYNAPS Dx (SDx), a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including...
